Amy Taylor

With a degree in biological sciences from the University of Cambridge, I joined AstraZeneca in February 2016 from global professional services firm, EY. I have previously worked for OC&C Strategy Consultants and rail construction company Crossrail.

As Business Planning & Operations Director, Chief Operating Office, BioPharmaceuticals R&D, I am working to ensure business operational excellence, drive efficient strategic decision making and support our scientific leadership. I am passionate about improving our business and making sure we can operate as effectively as possible to deliver the best outcomes for patients.

In October 2016, I founded and became chair of AstraZeneca’s Network of Women in the UK. The Network now has over 1,000 members.

AstraZeneca is committed to creating an inclusive workforce and increasing diversity in senior scientific roles. We have trialled blind-screening of CVs to remove unconscious bias to gender, and employ diverse panels for interviews to ensure the best person is recruited.

AstraZeneca’s Women as Leaders programme gives our female employees a chance to come together to discuss career progression and personal development, with a view to increasing awareness of opportunities and giving them the confidence to pursue these. Those who have attended the programme have seen a 30 per cent promotion rate and gained both sponsors and mentors.